Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute
API

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

Immuno-mycologics, Inc. — Funding, Investors & Profile — Capbase

← All companies

Compare History

Immuno-mycologics, Inc.

Private

Won 9 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: CN4DMLCJGCK9

Founded: —Source: [GOV]
Headquarters: NORMAN, OklahomaSource: [GOV]
Country: United StatesSource: [GOV]
Headcount: 0Source: [GOV]
Stage

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

Immuno-mycologics, Inc. has been awarded 9 US Small Business Innovation Research (SBIR/STTR) contracts totalling $5,280,795 between 2011 and 2020. These are non-dilutive federal research grants, not equity financing. The company is based in NORMAN, Oklahoma.

Funding rounds

9 rounds

9 rounds · latest SBIR Phase I award (HHS), Jan 2020

Investors

No investors recorded yet for Immuno-mycologics, Inc..

Add an investor

People

Leadership

BEVERLY CRIDERPrincipal investigatorSince 2015Source: [GOV]

Brandon NearyPrincipal investigatorSince 2014Source: [GOV]

Acquisitions

Immuno-mycologics, Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for Immuno-mycologics, Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Seed

Sector

Healthcare